Results 151 to 160 of about 69,512 (277)

Managing maternity: Moving care, not patients, using artificial intelligence (AI), internet‐of‐things (IOT) and point‐of‐care testing (POCT) devices

International Journal of Gynecology &Obstetrics, Volume 173, Issue 2, Page 602-613, May 2026.
Abstract The integration of artificial intelligence (AI) into healthcare is accelerating and maternity care is at a pivotal moment for the strategic implementation of these technologies. This article explores how AI‐assisted women's health innovations, often termed “FemTech,” may transform pregnancy care by addressing long‐standing disparities ...
Lin Foo, Mahesh Choolani, Aris Papageorghiou, Hema Divakar, Hassan Shehata, Nir Melamed, Gabriel Jones, Vyta Senikas, Eline M. Van der Beek, Nandita Palshetkar, Gabrielle Saccone, Vincenzo Berghella, Justin Konje, Bhaskar Bhatt, Augusto Cam, Moses Obimbo, Anne Beatrice Kihara, Moshe Hod   +17 more
wiley   +1 more source

Human Chorionic Gonadotropin as a Tumor Marker of Colorectal Cancer: A Case Report in a Non-pregnant Patient. [PDF]

Cureus
Castanheira D, Alves AR, Ferreira BO, Fernandes A, Duarte I.   +4 more
europepmc   +1 more source

A Case of Testicular Malakoplakia With Markedly High Signal Intensity on Fat‐Suppressed T1‐Weighted Images

IJU Case Reports, Volume 9, Issue 3, May 2026.
ABSTRACT Introduction Testicular malakoplakia is a very rare, chronic granulomatous inflammatory condition that frequently resembles testicular malignancy on imaging studies. Here, we report a case of testicular malakoplakia with characteristic magnetic resonance imaging (MRI) findings and present a brief review of the literature.
Fumiko Yagi, Hirotaka Akita, Takeo Kosaka, Akihisa Ueno, Teppei Kotera, Masato Kobayashi, Hideaki Mekada, Mototsugu Oya, Masahiro Jinzaki   +8 more
wiley   +1 more source

Isolated β-Human Chorionic Gonadotropin Elevation-From Pregnancy to Fragile X-associated Premature Ovarian Insufficiency. [PDF]

AACE Endocrinol Diabetes
Sharma PP.
europepmc   +1 more source

Sonographic Predictors and Long‐Term Reproductive Outcomes in Recurrent Cesarean Scar Pregnancy

Journal of Ultrasound in Medicine, Volume 45, Issue 5, Page 1059-1068, May 2026.
Objectives To explore the ultrasound findings, treatment strategies, and reproductive outcomes in patients with recurrent cesarean scar pregnancy (CSP), providing evidence for clinical management. Methods We identified 1371 confirmed CSP from 1517 initially screened cases (2012–2022) through blinded image review. From 159 subsequent live births in this
Jianan Shi, Xiaoping Gong, Hui Wang, Tiantian Sun, Guanjie Wang, Ping Chen, Mingtao Xiong   +6 more
wiley   +1 more source

Advancing fertility restoration strategies in androgen users: a call for reassessing the role of human chorionic gonadotropin therapy. [PDF]

F S Rep
Dokania S, Aphale P, Shekhar H.
europepmc   +1 more source

Recurrent Goiter, Hyperthyroidism, Galactorrhea and Amenorrhea due to a Thyrotropin ans Prolactin-Producing Pituitary Tumor [PDF]

, 1976
Erhardt, F., Fahlbusch, R., Horn, K., Pickardt, C. R., Scriba, Peter Christian, Werder, Klaus von   +5 more
core   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld, Nicole Kasatkin, Bi Liu Yu, Milen Velinov, Justin S. Brandt, Elena Ashkinadze   +5 more
wiley   +1 more source

The 10–23 DNAzyme in Biosensing and Diagnostics: Applications, Challenges, and Future Directions

Angewandte Chemie, Volume 138, Issue 18, 27 April 2026.
This review focuses on the 10–23 DNAzyme in diagnostics, spanning unregulated and regulated target‐recognition modes, and their functionalization across colorimetric, fluorescent, electrochemical, electrochemiluminescent, and intracellular biosensing strategies.
Connor Nurmi, Jake Brill, Sanne Roumans, Amal Mathai, John D. Brennan, Yingfu Li   +5 more
wiley   +2 more sources

Reply of the authors: Positioning human chorionic gonadotropin therapy for androgen users within a harm reduction framework. [PDF]

F S Rep
Smit DL, Verdegaal T, Bond P.
europepmc   +1 more source